7/14/2010

BG Medicine's use of a new patient recruitment model was revealed in a report as part of the design for its BioImage clinical trial, which aims to identify people at risk of serious cardiac conditions at an early stage. The trial will use MRI, CT angiography and 18F-FDG PET/CT to assess patients.

Related Summaries